(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

SEEGENE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

SEEGENE

ST13

US500000079323815

Classe

42, 44

Pedido

79323815

Registro

6966080

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

30/05/2023

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42, 44

Data de depósito

06/07/2021

Data de registro

31/01/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

31/01/2023

Última transação

31/01/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

KEELEY, ALISON

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

SEEGENE, INC.

Representantes

Max Vern Amster, Rothstein & Ebenstein LLP

Classificação técnica

Classes Nice

Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Research and development in the field of special testing using genetic engineering; biological servicestesting and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory servicespreparation and analysis of human body tissue and fluid samplesproviding reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical researchtreatmentdiagnosis; research and development of cell test products for medical researchtreatmentdiagnosis; research and development of body fluid and tissue sample analysis products for medical researchtreatmentdiagnosis; research and development agency of body fluid and tissue sample analysis products for medical researchtreatmentdiagnosis

Classe 44

Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnosticprophylactic and therapeutic properties of medical products; providing medical information relating to diagnosticprophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing servicesmedical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancerinfectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancerinfectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital servicesnot including dentistry services; medical clinic servicesnot including dentistry services; telemedicine servicesnot including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation servicesnot including dentistry services; medical equipment rental; providing health information servicesnot including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic servicesidentifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic servicesdiagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of personsanalysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

30/05/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/05/2023

FIMP

FINAL DISPOSITION PROCESSED

04/05/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/04/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

31/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

31/01/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/11/2022

PUBO

PUBLISHED FOR OPPOSITION

15/11/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/10/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/10/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

10/10/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/10/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

10/10/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/10/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/09/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/09/2022

RFNT

REFUSAL PROCESSED BY IB

06/06/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

16/05/2022

RFRR

REFUSAL PROCESSED BY MPU

16/05/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/04/2022

CNRT

NON-FINAL ACTION WRITTEN

31/03/2022

DOCK

ASSIGNED TO EXAMINER

25/03/2022

MAFR

APPLICATION FILING RECEIPT MAILED

30/10/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/10/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

22/10/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace SEEGENE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.